SE0402976L - Medicinsk produkt - Google Patents
Medicinsk produktInfo
- Publication number
- SE0402976L SE0402976L SE0402976A SE0402976A SE0402976L SE 0402976 L SE0402976 L SE 0402976L SE 0402976 A SE0402976 A SE 0402976A SE 0402976 A SE0402976 A SE 0402976A SE 0402976 L SE0402976 L SE 0402976L
- Authority
- SE
- Sweden
- Prior art keywords
- medical product
- container
- dose
- optionally
- inhalation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Packages (AREA)
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0402976A SE0402976L (sv) | 2004-12-03 | 2004-12-03 | Medicinsk produkt |
US11/049,696 US20060120969A1 (en) | 2004-12-03 | 2005-02-04 | Medical product for inhalation containing glucagon-like peptide-1 (GLP-1) |
KR1020077015300A KR20070095927A (ko) | 2004-12-03 | 2005-11-02 | 폐 흡입을 위한 글루카곤-형 펩타이드 약제를 포함하는의약품 |
RU2007124795/15A RU2007124795A (ru) | 2004-12-03 | 2005-11-02 | Медицинский продукт, содержащий лекарственное средство на основе глюкагоноподобного пептида, предназначенное для легочной ингаляции |
MX2007006533A MX2007006533A (es) | 2004-12-03 | 2005-11-02 | Un producto medico que comprende un medicamento peptidico tipo glucagon pretendido para inhalacion pulmonar. |
BRPI0518600-5A BRPI0518600A2 (pt) | 2004-12-03 | 2005-11-02 | produto mÉdico compreendendo um medicamento de peptÍdeo tipo glucagon, idealizado para inalaÇço pulmonar |
ZA200705376A ZA200705376B (en) | 2004-12-03 | 2005-11-02 | A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation |
PCT/SE2005/001648 WO2006059939A1 (en) | 2004-12-03 | 2005-11-02 | A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation |
CNA2005800476483A CN101111226A (zh) | 2004-12-03 | 2005-11-02 | 包含预期用于肺吸入的胰高血糖素样肽药物的医学产品 |
JP2007544302A JP2008521893A (ja) | 2004-12-03 | 2005-11-02 | 肺吸入用のグルカゴン様ペプチド薬物を含む医療品 |
AU2005310367A AU2005310367A1 (en) | 2004-12-03 | 2005-11-02 | A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation |
EP05801482A EP1827381A1 (en) | 2004-12-03 | 2005-11-02 | A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation |
CA002589118A CA2589118A1 (en) | 2004-12-03 | 2005-11-02 | A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation |
US11/272,859 US20060239933A1 (en) | 2004-12-03 | 2005-11-15 | Medical product |
IL183623A IL183623A0 (en) | 2004-12-03 | 2007-06-03 | A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0402976A SE0402976L (sv) | 2004-12-03 | 2004-12-03 | Medicinsk produkt |
Publications (2)
Publication Number | Publication Date |
---|---|
SE0402976D0 SE0402976D0 (sv) | 2004-12-03 |
SE0402976L true SE0402976L (sv) | 2006-06-04 |
Family
ID=33550603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0402976A SE0402976L (sv) | 2004-12-03 | 2004-12-03 | Medicinsk produkt |
Country Status (9)
Country | Link |
---|---|
US (2) | US20060120969A1 (sv) |
JP (1) | JP2008521893A (sv) |
CN (1) | CN101111226A (sv) |
BR (1) | BRPI0518600A2 (sv) |
IL (1) | IL183623A0 (sv) |
MX (1) | MX2007006533A (sv) |
RU (1) | RU2007124795A (sv) |
SE (1) | SE0402976L (sv) |
ZA (1) | ZA200705376B (sv) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
DK2280021T3 (en) | 1999-06-29 | 2016-05-02 | Mannkind Corp | Pharmaceutical formulations comprising insulin complexed to a diketopiperazine |
CA2479751C (en) | 2002-03-20 | 2008-06-03 | Trent Poole | Inhalation apparatus |
US20080260838A1 (en) * | 2003-08-01 | 2008-10-23 | Mannkind Corporation | Glucagon-like peptide 1 (glp-1) pharmaceutical formulations |
WO2010080964A1 (en) | 2009-01-08 | 2010-07-15 | Mannkind Corporation | Method for treating hyperglycemia with glp-1 |
US8921311B2 (en) | 2003-08-01 | 2014-12-30 | Mannkind Corporation | Method for treating hyperglycemia |
BRPI0514263B8 (pt) | 2004-08-20 | 2021-05-25 | Mannkind Corp | método para a síntese de bis-3,6-[4-aminobutil]-2,5-dicetopiperazina n-protegida |
DK2314298T3 (en) | 2004-08-23 | 2015-06-15 | Mannkind Corp | Microparticles comprising diketopiperazinsalte for drug delivery |
SE0402976L (sv) * | 2004-12-03 | 2006-06-04 | Mederio Ag | Medicinsk produkt |
US7803404B2 (en) | 2005-09-14 | 2010-09-28 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
US20130172274A1 (en) | 2005-12-20 | 2013-07-04 | Duke University | Methods and compositions for delivering active agents with enhanced pharmacological properties |
BRPI0707991B8 (pt) | 2006-02-22 | 2021-05-25 | Mannkind Corp | métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco |
DE102006031962A1 (de) * | 2006-07-11 | 2008-01-17 | Sanofi-Aventis Deutschland Gmbh | Amidiertes Insulin Glargin |
AU2008316634B2 (en) * | 2007-10-24 | 2014-02-27 | Mannkind Corporation | Method of preventing adverse effects by GLP-1 |
US8785396B2 (en) | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
CN101969928B (zh) * | 2007-10-24 | 2014-05-07 | 曼金德公司 | 活性剂的递送 |
US9358352B2 (en) | 2008-06-13 | 2016-06-07 | Mannkind Corporation | Dry powder drug delivery system and methods |
AU2009257311B2 (en) | 2008-06-13 | 2014-12-04 | Mannkind Corporation | A dry powder inhaler and system for drug delivery |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
DK2300083T3 (da) | 2008-06-20 | 2013-07-22 | Mannkind Corp | Interaktivt apparat og fremgangsmåde til realtids-profilering af inhalationsforsøg |
EP4074327A1 (en) | 2008-06-27 | 2022-10-19 | Duke University | Therapeutic agents comprising elastin-like peptides |
TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
RS56632B1 (sr) | 2008-10-17 | 2018-03-30 | Sanofi Aventis Deutschland | Kombinacija insulina i glp-1-agonista |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
PL2400950T3 (pl) | 2009-02-26 | 2019-12-31 | Glaxo Group Limited | Preparaty farmaceutyczne zawierające 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzylo)oksy]etoksy}heksylo)amino]-1-hydroksyetylo}-2-(hydroksymetylo)fenol |
US8538707B2 (en) | 2009-03-11 | 2013-09-17 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
KR101875969B1 (ko) | 2009-06-12 | 2018-07-06 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
JP5801997B2 (ja) * | 2009-07-07 | 2015-10-28 | ファイザー・リミテッドPfizer Limited | 薬品の組合せを吸入するための投薬ユニット、投薬ユニットのパック、および吸入器 |
WO2011017554A2 (en) | 2009-08-07 | 2011-02-10 | Mannkind Corporation | Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
WO2011056889A1 (en) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | An apparatus and method for simulating inhalation efforts |
PT3345593T (pt) | 2009-11-13 | 2023-11-27 | Sanofi Aventis Deutschland | Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina |
ES2855146T3 (es) | 2009-11-13 | 2021-09-23 | Sanofi Aventis Deutschland | Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina |
US20110118178A1 (en) * | 2009-11-13 | 2011-05-19 | Sanofi-Aventis Deutschland Gmbh | Method of treatment of diabetes type 2 comprising add-on therapy to insulin glargine and metformin |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
EP2552414A4 (en) * | 2010-03-31 | 2014-05-14 | Glenmark Pharmaceuticals Ltd | PHARMACEUTICAL POWDER COMPOSITION FOR INHALATION |
HUE031181T2 (en) | 2010-08-30 | 2017-06-28 | Sanofi Aventis Deutschland | Use of AVE0010 for the manufacture of a medicament for the treatment of type 2 diabetes |
ES2625858T3 (es) | 2011-04-01 | 2017-07-20 | Mannkind Corporation | Paquete de tipo blíster para cartuchos farmacéuticos |
US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
CN103917241A (zh) | 2011-08-29 | 2014-07-09 | 赛诺菲-安万特德国有限公司 | 用于2型糖尿病患者中的血糖控制的药物组合 |
AR087744A1 (es) | 2011-09-01 | 2014-04-16 | Sanofi Aventis Deutschland | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa |
JP6018640B2 (ja) | 2011-10-24 | 2016-11-02 | マンカインド コーポレイション | 疼痛を緩和するのに有効な鎮痛組成物並びに当該組成物を含む乾燥粉末及び乾燥粉末薬剤輸送システム |
ES2624294T3 (es) | 2012-07-12 | 2017-07-13 | Mannkind Corporation | Sistemas de suministro de fármacos en polvo seco |
EP2911690A1 (en) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Inhalable influenza vaccine compositions and methods |
EP2970149B1 (en) | 2013-03-15 | 2019-08-21 | MannKind Corporation | Microcrystalline diketopiperazine compositions and methods |
CN114848614A (zh) | 2013-07-18 | 2022-08-05 | 曼金德公司 | 热稳定性干粉药物组合物和方法 |
US20150038674A1 (en) * | 2013-08-05 | 2015-02-05 | Bayrak Bertan Boran | Use of glp-2 analogues in pulmonary diseases for therapeutic purpose |
CA2920488C (en) | 2013-08-05 | 2022-04-26 | Mannkind Corporation | Insufflation apparatus and methods |
WO2015148905A1 (en) * | 2014-03-28 | 2015-10-01 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
JP6970615B2 (ja) | 2014-12-12 | 2021-11-24 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | インスリングラルギン/リキシセナチド固定比処方 |
TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患治療 |
TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患之治療 |
MY193808A (en) * | 2016-01-11 | 2022-10-27 | Syqe Medical Ltd | Personal vaporizing device |
WO2023224577A1 (en) * | 2022-05-18 | 2023-11-23 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Inhalation compositions comprising micronized human insulin |
CN115192554A (zh) * | 2022-08-08 | 2022-10-18 | 浙江仙琚萃泽医药科技有限公司 | 无抛射剂的含肽吸入溶液剂及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9409496D0 (en) * | 1994-05-12 | 1994-06-29 | London Health Ass | Method for improving glycaemic control in diabetes |
US6720407B1 (en) * | 1998-08-28 | 2004-04-13 | Eli Lilly And Company | Method for administering insulinotropic peptides |
FI108518B (sv) * | 1999-04-23 | 2002-02-15 | Orion Yhtymae Oyj | Pulverinhalator för kombinationsmedicin |
US6528486B1 (en) * | 1999-07-12 | 2003-03-04 | Zealand Pharma A/S | Peptide agonists of GLP-1 activity |
US20010012829A1 (en) * | 2000-01-11 | 2001-08-09 | Keith Anderson | Transepithelial delivery GLP-1 derivatives |
US7186683B2 (en) * | 2000-09-18 | 2007-03-06 | Sanos Bioscience A/S | Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders |
SE518397C2 (sv) * | 2001-04-05 | 2002-10-01 | Microdrug Ag | Förfarande och anordning för frigörande av pulver och inhalatoranordning för administrering av medicinskt pulver |
SE524990C2 (sv) * | 2002-04-12 | 2004-11-09 | Microdrug Ag | Preparation av terapeutiskt torrt pulver samt förfarande för uppdelning och spridning i luft av medicinskt pulver |
SE0402976L (sv) * | 2004-12-03 | 2006-06-04 | Mederio Ag | Medicinsk produkt |
-
2004
- 2004-12-03 SE SE0402976A patent/SE0402976L/sv not_active Application Discontinuation
-
2005
- 2005-02-04 US US11/049,696 patent/US20060120969A1/en not_active Abandoned
- 2005-11-02 ZA ZA200705376A patent/ZA200705376B/xx unknown
- 2005-11-02 MX MX2007006533A patent/MX2007006533A/es unknown
- 2005-11-02 CN CNA2005800476483A patent/CN101111226A/zh active Pending
- 2005-11-02 BR BRPI0518600-5A patent/BRPI0518600A2/pt not_active Application Discontinuation
- 2005-11-02 JP JP2007544302A patent/JP2008521893A/ja active Pending
- 2005-11-02 RU RU2007124795/15A patent/RU2007124795A/ru not_active Application Discontinuation
- 2005-11-15 US US11/272,859 patent/US20060239933A1/en not_active Abandoned
-
2007
- 2007-06-03 IL IL183623A patent/IL183623A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL183623A0 (en) | 2007-09-20 |
US20060120969A1 (en) | 2006-06-08 |
SE0402976D0 (sv) | 2004-12-03 |
CN101111226A (zh) | 2008-01-23 |
JP2008521893A (ja) | 2008-06-26 |
US20060239933A1 (en) | 2006-10-26 |
RU2007124795A (ru) | 2009-01-10 |
ZA200705376B (en) | 2008-12-31 |
MX2007006533A (es) | 2007-08-02 |
BRPI0518600A2 (pt) | 2008-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0402976L (sv) | Medicinsk produkt | |
BRPI0417155A (pt) | produto medicinal compreendendo tiotrópio em um recipiente à prova de umidade | |
MY187036A (en) | Inhalation device and method | |
CY1110636T1 (el) | Προ-δοσιμετρημενος εισπνευστηρας ξηρης σκονης για φαρμακα ευαισθητα στην υγρασια | |
WO2012041938A3 (en) | Inhaler | |
MX371521B (es) | Sistema de inhalacion de polvo seco. | |
MX2010008234A (es) | Nueva dosificacion y formulacion. | |
EA200802012A1 (ru) | Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением | |
CA2791847A1 (en) | An improved dry powder drug delivery system | |
FI990914A (sv) | Pulverinhalator för kombinationsmedicin | |
DE602005016410D1 (de) | Verbessertes medizinprodukt | |
CY1110625T1 (el) | Μεθοδος για την χορηγηση τιοτροπιου | |
SE0402345D0 (sv) | A metered medication dose | |
JP2004533438A5 (sv) | ||
Skyler | Pulmonary insulin update | |
AR094287A1 (es) | Metodos y composiciones para administracion de oxibutinina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed | ||
NAV | Patent application has lapsed |